e-Drug3D

1343

FLUPHENAZINE ENANTHATE

DISCONTINUED


INN
FLUPHENAZINE ENANTHATE

(has an active metabolite)

cas 2746-81-8
CLASS

ANTIPSYCHOTIC
NERVOUS SYSTEM
ANTAGONIST
HYDROLYSED BY ESTERASES

ROUTE (list)

INJECTION

ATC code

N05AB02

PK parameters

Target

TARGET DOPAMINE D2 RECEPTOR

DrugCentral

D(2) dopamine receptor UNIPROT P14416 DRD2

D(2) dopamine receptor UNIPROT P14416 DRD2

Download SDF file Heptanoic acid, 2-[4-[3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl]-1-piperazinyl]ethyl ester

Formula:
C29H38F3N3O2S

Calculated chemical properties:

MW 549.69
NB_atoms 38
XLogP 6.83
PSA 39.664
NB_HD 0
NB_HA 5
fsp3 0.55
Lipinski(0=no;1=yes) 0

FDA
NDA 016110 (pdf not found) INN (FLUPHENAZINE ENANTHATE) PROLIXIN ENANTHATE (APOTHECON) APPROVAL= AP YEAR= 1967 DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL